Kuzniar Tomasz J, Pusalavidyasagar Snigdha, Gay Peter C, Morgenthaler Timothy I
Division of Pulmonary and Critical Care, Evanston Northwestern Healthcare, Evanston, IL, USA.
Sleep Breath. 2008 May;12(2):135-9. doi: 10.1007/s11325-007-0140-z.
Patients with complex sleep apnea syndrome (CompSAS) have obstructive sleep apnea but develop troublesome central sleep apnea activity or Cheyne-Stokes breathing when provided continuous positive airway pressure (CPAP) therapy. We examined whether CompSAS activity persists with long-term CPAP treatment. We retrospectively identified all patients with CompSAS who underwent two therapeutic polysomnograms (PSGs) separated by at least 1 month during 2003-2005. We compared PSG findings between the initial and follow-up study and noted clinical responses to therapy. We identified 13 CompSAS patients meeting criteria. Most follow-up PSGs were ordered after an abnormal overnight oximetry on CPAP or because of CPAP intolerance after 195 (49-562) days. The residual apnea-hypopnea index (AHI) on CPAP decreased from 26 (23-40) on the first PSG to 7 (3-21.5) on the follow-up PSG. Only seven patients reached AHI < 10 and 6 had AHI > or = 10 ("CPAP nonresponders") at follow-up. "CPAP nonresponders" were sleepier (Epworth Sleepiness Score 13 [12.5-14] vs 9 [6-9.5], p = 0.03) and trended toward lower body mass index (29.7 [28.6-31.6] vs 34.3 [32.5-35.1], p = 0.06). Both groups were equally compliant with CPAP therapy. Although the AHI tends to improve over time in CompSAS patients treated with CPAP, in this retrospective study nearly half-maintained a persistently elevated AHI. A prospective trial is merited to determine the optimal treatment for these patients.
复杂睡眠呼吸暂停综合征(CompSAS)患者存在阻塞性睡眠呼吸暂停,但在接受持续气道正压通气(CPAP)治疗时会出现令人困扰的中枢性睡眠呼吸暂停活动或潮式呼吸。我们研究了CompSAS活动在长期CPAP治疗后是否持续存在。我们回顾性地确定了2003年至2005年间所有接受过两次治疗性多导睡眠图(PSG)检查且间隔至少1个月的CompSAS患者。我们比较了初始研究和随访研究的PSG结果,并记录了治疗的临床反应。我们确定了13例符合标准的CompSAS患者。大多数随访PSG是在CPAP治疗期间夜间血氧饱和度异常后或在195(49 - 562)天后因CPAP不耐受而进行的。CPAP治疗时的残余呼吸暂停低通气指数(AHI)从首次PSG时的26(23 - 40)降至随访PSG时的7(3 - 21.5)。随访时只有7例患者的AHI < 10,6例患者的AHI >或= 10(“CPAP无反应者”)。“CPAP无反应者”更易困倦(Epworth嗜睡量表评分13 [12.5 - 14] 对比9 [6 - 9.5],p = 0.03),且体重指数有降低趋势(29.7 [28.6 - 31.6] 对比34.3 [32.5 - 35.1],p = 0.06)。两组对CPAP治疗的依从性相同。尽管接受CPAP治疗的CompSAS患者的AHI随时间有改善趋势,但在这项回顾性研究中,近一半患者的AHI持续升高。有必要进行一项前瞻性试验来确定这些患者的最佳治疗方法。